ResultsIQ

ResultsIQ › Latest results › Mangalam Organics Limited

Mangalam Organics Limited Q4 FY26 results deck summary

NSE: MANORG · BSE: 514418

Results deck of 1 Jun 2026, summarised by AI from the filing.

PAT ₹25.38 cr (FY25: ₹12.50 cr, +103.04%)

Key takeaways

  1. FY26 PAT PAT ₹25.38 cr (FY25: ₹12.50 cr, +103.04%)
  2. Input costs Decrease in input costs led to profitability for the year

Original filing on BSE

Mangalam Organics Limited Q1 FY27 results

As filed: Revenue ₹179 cr (+22% year on year), EBITDA ₹22.2 cr (+1% year on year), PAT ₹7.3 cr (−39% year on year), EBITDA margin 12.4% (−257 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹154 cr (+2% year on year), EBITDA ₹46.6 cr (+122% year on year), PAT ₹6.0 cr (+20% year on year), EBITDA margin 30.4% (+1,000 bps). Score 60 of 100, In line with trend. Revenue growth was below the company's own trend; EBITDA growth was well above it; profit growth was well below it. EBITDA margin rose 1000 bps year on year. Profit lagged EBITDA because of depreciation, interest or other income, not the business. Revenue fell 7% from last quarter. Share price after the results: −4.4% in 27 days (Nifty 500: +2.0%).
  • Q3 FY26: Revenue ₹164 cr (+33% year on year), EBITDA ₹19.3 cr (+21% year on year), PAT ₹4.3 cr (+8% year on year), EBITDA margin 11.8% (−116 bps). Score 58 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was in line with it; profit growth was well below it. EBITDA margin fell 116 bps year on year. Consolidated profit +8% but standalone -63%. Revenue grew on the previous quarter, against its usual seasonal pattern. Revenue rose ₹40.3 cr on a year ago, more than the ₹13.0 cr it added the year before. Share price after the results: −2.3% in 29 days (Nifty 500: −9.6%).
  • Q2 FY26: Revenue ₹158 cr (+14% year on year), EBITDA ₹0.0 cr (−100% year on year), PAT ₹3.0 cr (+167% year on year), EBITDA margin 0.0% (−870 bps). Score 35 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was well below it; profit before exceptional items growth was in line with it. EBITDA margin fell 870 bps year on year. Other income 525% of PBT. Profit fell 47% from last quarter. Profit before exceptional items rose ₹5.0 cr on a year ago, more than the ₹2.0 cr it added the year before. Share price after the results: −10.6% in 28 days (Nifty 500: −0.5%).
  • Q1 FY26: Revenue ₹147 cr (+25% year on year), EBITDA ₹22.0 cr (+100% year on year), PAT ₹12.0 cr (+300% year on year), EBITDA margin 15.0% (+564 bps). Score 69 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 564 bps year on year. Other income 27% of PBT. Tax rate 13%. Share price after the results: +27.3% in 28 days (Nifty 500: +1.7%).
  • Q4 FY25: Revenue ₹150 cr (+43% year on year), EBITDA ₹21.0 cr (+91% year on year), PAT ₹5.0 cr (+150% year on year), EBITDA margin 14.0% (+352 bps). Score 92 of 100, Above trend. Revenue and EBITDA growth were well above the company's own trend. EBITDA margin rose 352 bps year on year. Tax rate 14%. Consolidated profit +150% but standalone -33%. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +54.0% in 30 days (Nifty 500: +7.6%).
  • Q3 FY25: Revenue ₹124 cr (+12% year on year), EBITDA ₹16.0 cr (+60% year on year), PAT ₹4.0 cr (+300% year on year), EBITDA margin 12.9% (+389 bps). Score 84 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA growth was well above it. EBITDA margin rose 389 bps year on year. Revenue fell 10% from last quarter.
  • Q2 FY25: Revenue ₹138 cr (−18% year on year), EBITDA ₹12.0 cr (+20% year on year), PAT ₹2.0 cr (+100% year on year), EBITDA margin 8.7% (+278 bps). Score 55 of 100, In line with trend. EBITDA margin rose 278 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Mangalam Organics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.